Tradestie Institutional Equity Comparison Engine
TYRA vs ANNX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANNX Overall Edge
ANNX Captures Institutional Edge (2โ1 Pillars ยท 1โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Annexon, Inc. Common Stock (ANNX) driven by superior Momentum & Technical, Options & Structure while TYRA counters with relative strength in Growth & Margin. Fundamentally, TYRA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TYRA sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TYRA N/M vs ANNX N/M Fwd P/E
Growth & Margin Winner
TYRA
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
ANNX
1Y +24.4% vs +28.0% ยท 52W Pos 18% vs 18%
Options & Structure Winner
ANNX
BREAKDOWN (3rd %ile IV) vs BREAKDOWN (100th %ile IV)
TYRA
NASDAQ
Tyra Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$19.57
-0.86% 1D
Market Cap
$1.4B
1M Return
+1.19%
1Y Return
+24.41%
Forward P/E
N/M
Unified AI Score
34.0 / 100
SELL
Tech 30.0
Fund 48.0
Flow 66.0
Mom 50.0
ANNX
NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.47
-2.8% 1D
Market Cap
$747.8M
1M Return
-13.47%
1Y Return
+28.04%
Forward P/E
N/M
Unified AI Score
43.5 / 100
HOLD
Tech 37.0
Fund 55.0
Flow 72.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TYRA +24.41%
ANNX +28.04%
Spread: +3.63 pp (ANNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TYRA TTM Op. Margin: 0.0%
ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TYRA vs ANNX. Trailing 12-month operating profitability (TYRA 0.0% vs ANNX 0.0%) and valuation multiples (TYRA N/M vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TYRA | ANNX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | $747.8M | Larger Scale | TYRA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -34.9% | -130.8% | Higher ROE | TYRA |
| 52-Week Range Position Momentum | 18% ($15โ$41) | 18% ($3โ$7) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.79ฮฒ ยท 48% Vol | 1.70ฮฒ ยท 63% Vol | Lower Realized Risk | TYRA |
| Unified Institutional Score Composite Signal | 34.0 / 100 (SELL) | 43.5 / 100 (HOLD) | Higher Composite | ANNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TYRA vs ANNX Buy Guide
TYRA
BREAKDOWN
77d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
ANNX
BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TYRA nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.